Opens in a new tab

GXD-Bio v Myriad Genetics (CFI, 14 February 2025)

Date14 February 2025
CourtCFI
DivisionMunich (DE) Local Division
Type of actionPreliminary objection
Registry referenceApp_51844/2024 · ORD_68782/2024
PartiesGXD-Bio Corporation v. Myriad Genetics S.r.l., Myriad GmbH, Myriad Genetics S.A.S., Myriad Genetics B.V., Myriad Genetics, Inc., Myriad Servic…

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By an order of 14 February 2025 (ORD_68782/2024, UPC_CFI_437/2024), Ulrike Voß, judge rapporteur in the Munich Local Division, rejected the preliminary objection raised by eight Myriad group companies sued by GXD-Bio Corporation for infringement of EP 3 346 403. The defendants challenged the UPC’s competence over acts preceding GXD-Bio’s registration as proprietor, the related claims having been assigned by the former proprietors. The judge treated this as a question of standing, belonging to the merits, and granted leave to appeal.

Question

Does a challenge to the claimant’s right to sue for acts preceding its entry in the register, based on Arts 47 and 68 UPCA, fall within the preliminary objection to jurisdiction under Rule 19.1?

Decision

The grounds for a preliminary objection listed in Rule 19.1 are exhaustive (paragraph 13, citing Aylo v Dish). The objections concerned standing and substantive entitlement, not jurisdiction under Art. 32 UPCA, which says nothing about who may bring an action (paragraphs 14 and 15). Arts 47 and 68 are not implicitly part of Art. 32, as the structure of the UPCA confirms (paragraph 16). These issues belong to the main proceedings (paragraph 17). Subject-matter jurisdiction follows from Arts 32(1)(a), 2(g) and 3(c) UPCA, the patent not having expired by 1 June 2023 (paragraph 18). The auxiliary request to decide the objection in the main proceedings failed for the same reasons (paragraph 19). Leave to appeal was granted, since the question of law concerns many cases (paragraph 21).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Arts 2(g), 3(c), 32(1)(a), 47 and 68(1)
Rules of Procedure
Rules 19.1, 20.1, 21.1 and 220.2, recital 8
Case law cited
Aylo v Dish, Court of Appeal, 3 September 2024

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Local and central divisions (UPC).

Dhenne Avocats blog: The Transitional Period and the UPC: Coordinating Two Judicial Orders.

Publications by Matthieu Dhenne: Pleading the Long Arm: What a UPC Statement of Claim Must Carry Beyond Jurisdiction, Valeo v. Bosch and the Redistribution of Cases Within the UPC (Kluwer Patent Blog).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Preliminary objection
Outcome (Dhenne Avocats summary)
La juge rapporteure rejette l'exception préliminaire des sociétés Myriad, la contestation du droit d'agir pour les actes antérieurs à l'inscription de GXD-Bio relevant de la qualité pour agir et du fond, et autorise l'appel.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 3 346 403Mentioned in the analysis (role not qualified)
Also mentioned in 2 other decision(s): GXD-Bio v Myriad International (CFI, UPC_CFI_437/2024, 19 December 202 · GXD-Bio v Myriad International (CFI, 26 November 2024)
not recordednot recordednot recordedEspacenet
links not checked
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.